当前位置: 首页 > 期刊 > 《中国实用医药》 > 2008年第32期
编号:11702085
顺铂联合白介素-2治疗恶性胸腔积液疗效观察
http://www.100md.com 2008年11月25日 《中国实用医药》 2008年第32期
顺铂联合白介素-2治疗恶性胸腔积液疗效观察

     【摘要】 目的 观察顺铂联合白介素-2胸腔灌注治疗恶性胸腔积液的临床疗效和毒副反应。方法 采用胸腔闭式引流术,观察组在胸腔内注入顺铂60 mg、白介素-2 100万U,对照组在胸腔内注入顺铂60 mg。每周1次,共1~3次。观察疗效、生活质量、生存率和毒副反应。结果 观察组有效率为81.82%,照组有效率为55.00%,差异有显著性(P<0.05)。两组无严重不良反应,均可耐受。结论 顺铂和白介素-2联合胸腔内注射,消除胸水作用明显,值得临床推广。

    【关键词】 顺铂;白介素-2;恶性胸腔积液

    Therapeutic effects of thoracic cavity of cisplatin and interleukin-2 in maligant pleural effusion

    Zhu zao-jun Henan Anyang iron and steel group staff general Hospital Anyang 455004,China

    【Abstract】 Objective To evaluate the therapeutic effect and side effect of thoracic cavity injection of cisplatin and interleukin-2 in maligant pleural effusion.Methods In theray group,25 cases with maligant pleural effusion, after chest drainage,were injected into pleural cavity with interleukin-2 one millionaire unit and cisplatin 60 mg weekly for 1~3 weeks,and in control group,22 cases were injected only with cisplatin 60 mg weekly for 1~3 weeks.The efficacy,quality of life,relapse rate and toxicities were evaluated.Results The response rate after 6 months in treatment group was lower than that in the control group (P<0.05). The toxicities of two groups were tolerated.Conclusion The thoracic cavity injection of cisplatin and interleukin-2 in maligant pleural effusion is an effective way and worth in clnical application. ......

您现在查看是摘要页,全文长 4968 字符